The FDA recently granted Breathe Technologies Inc 510(k) clearance to market its Sleep System CPAP in the United States for treatment of obstructive sleep apnea.
The Sleep System, which utilizes miniaturized technologies coupled with user-centric design, features a comfortable, discreet interface that is both effective and easy to set up. The system also includes a redesigned humidification system, an interactive patient touch-screen, and a smart pressure ramp function.
“Our approach to respiratory care is centered on improving patients’ quality of life,” said Larry Mastrovich, CEO of Breathe Technologies. “Based on extensive research with patients and clinicians, we have designed a clinically effective system with unique features.”